Back to Search
PERCY BALLARD, M.D.
M.D.
Psychiatry Physician
NPI: 1902067424Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
236476(MA)
Research & Publications (20)
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 17869514·Bioorg Med Chem Lett·2007
7-preclinical
Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket.
PMID 16380259·Bioorg Med Chem Lett·2006
7-preclinical
Inhibitors of epidermal growth factor receptor tyrosine kinase: optimisation of potency and in vivo pharmacokinetics.
PMID 16806916·Bioorg Med Chem Lett·2006
7-preclinical
Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide.
PMID 16326985·Pediatr Res·2006
7-preclinical
5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 16055332·Bioorg Med Chem Lett·2005
7-preclinical
Surfactant protein profile of pulmonary surfactant in premature infants.
PMID 12904326·Am J Respir Crit Care Med·2003
4-observational
Errors in the measurement of endometrial depth using transvaginal sonography in postmenopausal women on tamoxifen: random error is reduced using saline instillation sonography.
PMID 10895453·Ultrasound Obstet Gynecol·2000
8-other
Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein.
PMID 19329538·Am J Physiol Lung Cell Mol Physiol·2009
8-other
Proteolytic activation of the cytotoxic phenotype during human NK cell development.
PMID 19570824·J Immunol·2009
8-other
Postnatal estradiol up-regulates lung nitric oxide synthases and improves lung function in bronchopulmonary dysplasia.
PMID 19151197·Am J Respir Crit Care Med·2009
7-preclinical
Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 18313293·Bioorg Med Chem Lett·2008
7-preclinical
Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia.
PMID 18500734·Pediatr Pulmonol·2008
4-observational
One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial.
PMID 18534620·J Pediatr·2008
2-rct
Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.
PMID 18310205·Pediatrics·2008
2-rct
Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
PMID 18182285·Bioorg Med Chem Lett·2008
7-preclinical
Determination of microsome and hepatocyte scaling factors for in vitro/in vivo extrapolation in the rat and dog.
PMID 18988082·Xenobiotica·2008
7-preclinical
A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
PMID 18061446·Bioorg Med Chem Lett·2008
7-preclinical
Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
PMID 17417700·Calcif Tissue Int·2007
2-rct
Surfactant function and composition in premature infants treated with inhaled nitric oxide.
PMID 17671061·Pediatrics·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1340 BOYLSTON ST
BOSTON, MA 02215 - Phone
- (617) 267-0900
Quick Facts
- NPI
- 1902067424
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile